Call for Papers Antiphospholipid Syndrome Beyond Thrombosis – Frontiers-Immunology
Frontiers-Immunology shared a post on LinkedIn:
“Call for Papers: Antiphospholipid syndrome – beyond thrombosis (Frontiers in Lupus)
‘Antiphospholipid syndrome – beyond thrombosis’ is now welcoming submissions that push APS research past the classic ‘clotting-only’ framing – especially where APS intersects with lupus.
APS is defined by thrombotic risk in the presence of antiphospholipid antibodies (aPL). But newer work suggests the biology is not purely coagulation-driven. Complement activation, immune–coagulation cross-talk, and organ-specific manifestations (including pregnancy morbidity and possible inflammatory contributors to APS nephropathy) point to mechanisms that may matter for outcomes — and for treatment choices.
This Research Topic focuses on what we need to understand next:
- Inflammation and complement activation as drivers of APS manifestations
- Therapies beyond long-term anticoagulation (including approaches for treatment-resistant disease, high-risk aPL patterns, or arterial thrombosis)
- Novel biomarkers for APS diagnosis and risk stratification
- Multidisciplinary strategies for obstetric APS management
- Implications of the 2023 ACR/EULAR classification criteria for diagnosis and treatment
- Genetic and epigenetic factors shaping APS pathogenesis and progression
- Risk of SLE development in patients with primary APS
- APS emergence in SLE patients who were initially serologically negative
If your work helps clarify how thrombotic and inflammatory pathways interact in APS, and what that means for patients, this collection is a strong fit, including original research, reviews, and case analyses.
Manuscript Summary deadline (optional): 1 February 2026
Manuscript deadline: 22 May 2026
Led by: Magdalena Celińska-Lowenhoff, Teresa Iwaniec, Chaim Putterman
In: Frontiers in Lupus
Submit here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG